Basit öğe kaydını göster

dc.contributor.authorSkoneczna, Iwona Anna
dc.contributor.authorTannock, Ian
dc.contributor.authorFizazi, Karim
dc.contributor.authorIvanov, Sergei
dc.contributor.authorKarlsson, Camilla Thellenberg
dc.contributor.authorFlechon, Aude
dc.contributor.authorOrlandi, Francisco Jorquera
dc.contributor.authorGravis, Gwenaelle
dc.contributor.authorMatveev, Vsevolod B.
dc.contributor.authorBavbek, Sevil E.
dc.contributor.authorGil, Thierry
dc.contributor.authorViana, Luciano S.
dc.contributor.authorAren, Osvaldo Rudy
dc.contributor.authorKaryakin, Oleg
dc.contributor.authorElliott, Tony
dc.contributor.authorBirtle, Alison J.
dc.contributor.authorMagherini, Emmanuelle
dc.contributor.authorHatteville, Laurence
dc.contributor.authorTombal, Bertrand
dc.contributor.authorRosenthal, Mark
dc.date.accessioned2021-03-03T19:35:48Z
dc.date.available2021-03-03T19:35:48Z
dc.identifier.citationTannock I., Fizazi K., Ivanov S., Karlsson C. T. , Flechon A., Skoneczna I. A. , Orlandi F. J. , Gravis G., Matveev V. B. , Bavbek S. E. , et al., "Aflibercept versus placebo in combination with docetaxel/prednisone for first-line treatment of men with metastatic castration-resistant prostate cancer (mCRPC): Results from the multinational phase III trial (VENICE)", Genitourinary Cancers Symposium of the Conquer-Cancer-Foundation of American-Society-of-Clinical-Oncology (ASCO), Florida, Amerika Birleşik Devletleri, 14 - 16 Şubat 2013, cilt.31
dc.identifier.othervv_1032021
dc.identifier.otherav_5571e743-7519-4e83-aa47-667ae026b04d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/60397
dc.identifier.urihttps://doi.org/10.1200/jco.2013.31.6_suppl.13
dc.language.isoeng
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.titleAflibercept versus placebo in combination with docetaxel/prednisone for first-line treatment of men with metastatic castration-resistant prostate cancer (mCRPC): Results from the multinational phase III trial (VENICE)
dc.typeBildiri
dc.contributor.department, ,
dc.identifier.volume31
dc.contributor.firstauthorID141317


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster